Heme Degradation (Bilirubin Pathway)

1. 1

   Heme + O₂ + NADPH + H⁺ → biliverdin IXα + Fe²⁺/³⁺ + CO + NADP⁺ + H₂O

   Heme oxygenase (HO-1 inducible; HO-2 constitutive) 1.14.14.18 ST-0185 Irreversible rate-limiting NADP+ NADPH Fe2+ Heme/cytochrome O2 H2O
   In Heme O2 NADPH H+

   Out Biliverdin IX-alpha Fe2+/3+ CO NADP+ H2O
   › Notes

   Heme oxygenase (HO-1 inducible; HO-2 constitutive) cleaves the α-methene bridge of heme in macrophage endoplasmic reticulum. It requires molecular oxygen, NADPH, and electrons delivered by NADPH–cytochrome P450 reductase; this is the rate-limiting, committed, and irreversible step of heme catabolism, and it liberates iron for recycling plus carbon monoxide.

2. 2

   Biliverdin IXα + NADPH + H⁺ → bilirubin IXα + NADP⁺

   Biliverdin reductase (BLVRA) 1.3.1.24 ST-0186 Irreversible/directional NADP+ NADPH
   In Biliverdin IX-alpha NADPH H+

   Out Bilirubin IX-alpha NADP+
   › Notes

   Cytosolic biliverdin reductase reduces the central methine bridge to form unconjugated bilirubin. NADPH is required; bilirubin is hydrophobic and is released into plasma bound tightly but noncovalently to albumin.

3. 3

   Unconjugated bilirubin (albumin-bound) → hepatocyte-associated unconjugated bilirubin

   OATP1B1/OATP1B3 uptake + ligandin binding (transport, not enzymatic) ST-0187 Irreversible/directional
   In Unconjugated bilirubin

   Out Hepatocyte-associated unconjugated bilirubin
   › Notes

   Hepatic sinusoidal uptake is carrier-mediated (not a covalent enzymatic conversion), followed by cytosolic binding to ligandin/GST proteins. Albumin-bound bilirubin cannot be filtered by the kidney and is not directly excreted in urine.

4. 4

   Bilirubin + 2 UDP-glucuronic acid → bilirubin mono- and predominantly diglucuronide + 2 UDP

   Bilirubin UDP-glucuronosyltransferase (UGT1A1) 2.4.1.17 ST-0188 Irreversible/directional rate-limiting UDP-glucuronic acid
   In Bilirubin UDP-glucuronate

   Out Bilirubin diglucuronide UDP
   › Notes

   Endoplasmic-reticulum bilirubin UDP-glucuronosyltransferase (UGT1A1) conjugates the two propionic-acid side chains using UDP-glucuronic acid. This is the rate-limiting enzymatic step of hepatic bilirubin clearance and produces water-soluble conjugated bilirubin; bilirubin diglucuronide is then actively secreted into bile by the ATP-dependent canalicular transporter MRP2 (ABCC2).

5. 5

   Conjugated bilirubin → unconjugated bilirubin → urobilinogen

   ↪ unconjugated bilirubin → urobilinogen

   Bacterial beta-glucuronidases + reductases (gut microbiota) ST-0189 Irreversible/directional
   In Conjugated bilirubin

   Out Unconjugated bilirubin
   › Notes

   Intestinal bacterial β-glucuronidases deconjugate bilirubin glucuronides, and bacterial reductases convert bilirubin to colorless urobilinogen. These are microbial rather than human enzymatic steps; no host ATP is directly consumed.

6. 6

   Urobilinogen → stercobilin (feces) or urobilin (urine)

   Non-enzymatic/bacterial oxidation to stercobilin/urobilin ST-0190 Irreversible/directional
   In Urobilinogen

   Out Stercobilin (feces) or urobilin
   › Notes

   Most urobilinogen is oxidized in the intestine to brown stercobilin and excreted in feces; a portion is reabsorbed through portal blood, and a small fraction escapes hepatic uptake and is oxidized to yellow urobilin in urine. Enterohepatic cycling returns much of the absorbed urobilinogen to bile.

Showing all 6 steps.

Overview

Heme degradation disposes of heme released predominantly during turnover of senescent erythrocytes and converts its tetrapyrrole ring into bilirubin for biliary excretion. Macrophages first form biliverdin and unconjugated bilirubin; the water-insoluble bilirubin travels bound to albumin to liver, where it is conjugated with glucuronic acid and secreted into bile. Intestinal bacterial metabolism converts bilirubin-derived pigments to urobilinogen and ultimately to fecal stercobilin and urinary urobilin.

Cellular location

Initial heme breakdown is most active in reticuloendothelial macrophages of spleen, liver (Kupffer cells), and bone marrow, with heme oxygenase localized to the endoplasmic reticulum. Hepatic uptake, cytosolic ligand binding, and conjugation occur in hepatocytes; UDP-glucuronosyltransferase 1A1 (UGT1A1) is an endoplasmic-reticulum enzyme. Biliary secretion occurs across the canalicular membrane, while subsequent reduction/deconjugation occurs in the intestinal lumen through the microbiota.

Net energetics

Per heme molecule, heme oxygenase consumes 1 NADPH and O₂, and biliverdin reductase consumes 1 additional NADPH. Formation of bilirubin diglucuronide uses 2 UDP-glucuronic acid; their synthesis from glucose/UDP-glucose carries an upstream UTP-equivalent cost, while canalicular export by MRP2 is ATP dependent. No ATP is made by the pathway; recovered iron is reutilized for heme synthesis or stored as ferritin/hemosiderin.

Clinical significance

Bilirubin handling is clinically central because elevated unconjugated and conjugated bilirubin have distinct diagnostic implications. Unconjugated hyperbilirubinemia occurs with hemolysis, impaired uptake, or reduced conjugation (physiologic neonatal jaundice, Gilbert syndrome, Crigler–Najjar syndrome); because unconjugated bilirubin is lipid-soluble, severe neonatal elevation can cross the blood–brain barrier and cause kernicterus. Conjugated hyperbilirubinemia occurs with impaired canalicular excretion or biliary obstruction and can cause dark urine, whereas complete obstruction diminishes intestinal stercobilin and produces pale stools. Nucleotide metabolism supplies the purine and pyrimidine building blocks required for DNA replication, RNA synthesis, and energy carriers such as ATP and GTP, through both de novo synthesis and salvage of preformed bases. Because proliferating and immune cells have especially high nucleotide demand, these pathways are prominent targets of chemotherapeutic and immunosuppressive drugs. Inherited defects in nucleotide handling produce disorders ranging from gout to severe combined immunodeficiency.